ZYTO Corp

1
Revolutionizing the Way People Make Decisions!

• ZYTO Corp
• November 2007
• Trading Symbol ZYTC

2
Forward Looking Statements
All statements, other than historical financial
information, may be deemed to be forward looking
statements within the meaning of Section 27A of
the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of
1934, as amended. All statements that address
activities, outcomes and other matters that
should or may occur in the future, including,
without limitation, statements regarding the
financial position, business strategy and other
plans and objectives for the companys future
operations, are forward looking statements.
Although the company believes the expectations
expressed in such forward-looking statements are
based on reasonable assumptions, such statements
are not guarantees of future performance and
actual results or developments may differ
materially from those in the forward looking
statements. The company has no obligation and
makes no undertaking to publicly update or revise
any forward looking statements. You should not
place undue reliance on forward looking
statements. They are subject to known and unknown
risks, uncertainties and other factors that may
affect the companys operations, markets,
products, services and prices and cause its
actual results, performance or achievements to be
materially different from any future results,
performance or achievements expressed or implied
by the forward looking statements. In addition to
any assumptions and other factors referred to
specifically in connection with forward looking
statements, risks, uncertainties and factors that
could cause the companys actual results to
differ materially from those indicated in any
forward looking statement include, but are not
limited to increased competition the impact of
federal, state and local government regulation
the financial impact of accounting regulations
and critical accounting policies conditions in
capital markets and changes in interest rates
and any other factors listed in the reports we
have filed and may file with the Securities and
Exchange Commission (SEC). The company disclaims
any intention or obligation to update or revise
any forward looking statements, whether as a
result of new information, future events or
otherwise.
3
Company Profile
ZYTO Corp is revolutionizing the way people make
decisions. Using the principles of biology,
quantum physics, and the science of information,
we facilitate meaningful communication between
computers and the human body in a sequence of
elegance the computer poses the question, the
body answers, and not a word is spoken. The
process is a stimulus-response exchange. The
computer outputs a digital signature representing
the question, which takes many forms depending on
the context of the experience. Its called a
bio-survey. Each bio-survey is designed to give
decision makers subconscious data. This approach
to information gathering has proven its value
over the last several years in hundreds of
medical practices and with tens of thousands of
patients around the world. As a software
company ZYTO continues to innovate solutions to
every day decision needs. New applications will
be sold directly to consumers and deployed via
cell phones and over the internet. This allows
ZYTO to experience rapid growth and significant
profit margins.
Main Office 1266 S. 1380 W. Orem, UT
84058 Phone [phone] Fax [phone] Web
www.ZYTO.com Incorporated December 30, 2004
began operation January 2, 2005 Quoted in Pink
Sheets Trading Symbol ZYTC
4
Europe Office Dublin, Ireland (scheduled for
early 2008)
Main Office Orem, Utah
Turkey
Japan
U.S.A.
China
China Office Shanghai
Australia
ZYTO Offices
Joint Venture Partners or Independent Reps
Brazil Office Sao Paulo (scheduled for late 2008)
South Africa
5
Board of Directors
Vaughn R Cook, OMD Vaughn R Cook is
President/CEO of ZYTO Corp. For over twenty years
Dr. Cook has worked in the Complementary and
Alternative Medical field. He has specialized in
biofeedback applications that integrate western
and eastern medicine. He has traveled extensively
and taught principles of alternative medicine
throughout the United States and in many
countries. He has developed two computer-based
systems used by health professionals around the
world. The most recent of these is the LSA
System. In addition to his experience with
technology he has owned and operated health care
facilities specializing in holistic health. This
clinical background has allowed him to develop
equipment from the perspective of a practicing
health care professional, which combined with an
extensive background in business, has resulted in
technology that is clinically effective and
financially practical.
Dennis A. Robbins Ph.D., MPH Dennis Robbins,
Ph.D,M.P.H. is a prominent author, speaker ,
educator and advisor on quality, new technologies
and health care ethics. Over the past 25 years,
he has developed an eclectic blend of academic
and national consulting experience having worked
with major universities, medical facilities,
state and national government, presidential and
White House Commissions, health care systems,
trade associations/organizations, the
payor/reimbursement community and diverse
practitioners. Robbins was a National Fund for
Medical Education Fellow in the Kennedy
Interfaculty Program at Harvard, where he was a
visiting scholar and research fellow. Dr. Robbins
holds a PhD in Philosophy from Boston College and
a postdoctoral Masters in Public Health from
Harvard. Dr. Robbins has authored eight books and
over 250 articles, chapters and reviews. He has
served as a columnist and national advisor for
several health care journals. He also teaches
Complementary and Alternative Medicine courses at
Arizona State University.
Marc Leib, M.D., J.D. Dr. Leib is a prominent
physician with specialized knowledge in health
law, regulation, and policy. Dr. Leib obtained
his undergraduate degree at Stanford University
and attended medical school at the University of
Arizona. After completing his residency and
fellowship in Madison, Wisconsin, Dr. Leib
practiced anesthesia for approximately two
decades. Dr. Leib also attended law school and
subsequently practiced law at the Washington D.C.
office of a multi-national law firm. His practice
consisted exclusively of health care law,
predominantly Medicare regulatory affairs and
Health Insurance Portability and Accountability
Act (HIPAA) issues. Dr. Leib has served as
President of the Arizona Medical Association
(ArMA) and the Arizona Society of
Anesthesiologists (AzSA). He serves on the Board
of Directors for various organizations. He has
published articles in both medical and legal
journals and currently writes essays and articles
of interest for various health care publications.
In addition, Dr. Leib has served on the Board of
Directors for MICA, Arizona's physician-owned
professional liability insurance company, for
approximately 10 years. He is currently serving
as the Chief Medical Officer of the Arizona
Health Care Cost Containment System (AHCCCS),
Arizona's Medicaid program.
6
Board of Directors
Duane Davis, Vice President of Sales of ZYTO
Corp. For over ten years, Mr. Davis has worked in
the Alternative Medical field. Mr. Davis has
spent extensive time teaching and educating
practitioners in the use and success of energetic
technologies. From 1998 to 2003, Mr. Davis served
in various leadership positions with BioMeridian
Corporation. From 1976 to the time he joined
BioMeridian Corporation, Mr. Davis worked with
the Holding company Davcor and its wholly owned
subsidiaries Affiliated Metals, Affiliated
Industrial Products, Aerofast Industrial
Products, Leasco, Superior Building Products,
Property Enterprises, and Davis Construction.
Positions of responsibility included all aspects
of the company from sales to senior management,
including the Board of Directors. Mr. Davis
joined the ZYTO team in January 2005.
Goodwin Wang Goodwin Wang, born in Hangzhou, the
Peoples Republic of China, Mr. Wang completed
his first degree in Aircraft Design and
Manufacturing, before departing for the USA,
where he obtained his Masters degree in Computer
Science from Arizona State University, and other
substantial executive learning from Harvard and
New York University. Mr. Wang began his career
with TNT Inc. in Phoenix, as an Engineering
Consultant in the electronics component
manufacturing industry. He then immigrated to
Vancouver, Canada, where he joined Sino-Cad
Circuits Canada Ltd, a multi-layer circuit
board manufacturer in a business development
capacity. In 1992, Mr. Wang joined Master
Technology Corp, a Canadian manufacturer and
distributor of telecommunication equipment. Over
the next four-year period, Mr. Wang led the
expansion of the Company into the PRC. As Head of
Greater China region, Mr. Wangs broad scope of
responsibilities covered sourcing and negotiation
of joint ventures, establishment of
organizational structures, as well as management
of subsidiary operations in China. Mr. Wangs
career in executive search and management
consulting began when he joined Ward Howell,
Shanghai in 1996. Two years later, Mr. Wang
established SES Investment (China), a WOFE based
in Shanghai, and has assisted Fortune 500
companies successfully launching into China. In
2002, Mr. Wang was honorably invited as a Senior
Strategic Advisor by the Shanghai Government to
develop human capital and introduce foreign
investment to the area of Shanghai.
7
Management
Vaughn R Cook, OMD Vaughn R Cook is
President/CEO of ZYTO Corp. For over twenty years
Dr. Cook has worked in the Complementary and
Alternative Medical field. He has specialized in
biofeedback applications that integrate western
and eastern medicine. He has traveled extensively
and taught principles of alternative medicine
throughout the United States and in many
countries. He has developed two computer-based
systems used by health professionals around the
world. The most recent of these is the LSA
System. In addition to his experience with
technology he has owned and operated health care
facilities specializing in holistic health. This
clinical background has allowed him to develop
equipment from the perspective of a practicing
health care professional, which combined with an
extensive background in business, has resulted in
technology that is clinically effective and
financially practical.
Kami Howard, COO Kami Howard serves as Chief
Operating Officer for ZYTO Corp and its
subsidiaries. Ms. Howard joined ZYTO in the
spring of 2007 and is responsible for all aspects
of operational management. Previously, Ms.
Howard spent five years at Browz, LLC where she
was a Vice President and served as Corporate
Controller. From 2000 to 2003, Ms. Howard served
as Vice President and Corporate Controller for
BioMeridian Corporation and its subsidiaries.
Prior to her appointment at BioMeridian, Ms.
Howard served in various senior financial
positions. She holds a B.S. in accounting and a
master's degree in business administration.
Marianne Miller, VP,Controller Marianne Miller
serves as Vice President and Corporate
Controller. Ms. Miller joined ZYTO in January
2005 and is responsible for all accounting and
human resource functions. From 2004 to 2005, Ms.
Miller served as Corporate Controller for Digital
Health Corp. Prior to her appointment at Digital
Health, Ms. Millers career included several
years in retail operations including scheduling,
purchasing, merchandising, sales and management.
Duane Davis, VP Sales Duane Davis serves as Vice
President of Sales. For over ten years, Mr.
Davis has worked in the Alternative Medical
field. Mr. Davis has spent extensive time
teaching and educating practitioners in the use
and success of energetic technologies. From 1998
to 2003, Mr. Davis served in various leadership
positions with BioMeridian Corporation. From 1976
to the time he joined BioMeridian Corporation,
Mr. Davis worked with the Holding company Davcor
and its wholly owned subsidiaries Affiliated
Metals, Affiliated Industrial Products, Aerofast
Industrial Products, Leasco, Superior Building
Products, Property Enterprises, and Davis
Construction. Positions of responsibility
included all aspects of the company from sales to
senior management, including the Board of
Directors. Mr. Davis joined the ZYTO team in
January 2005.
David Erickson, VP Software Development Mr.
Erickson serves as VP Software Development. Mr.
Erickson has been in the software industry for
over 13 years. He has worked for companies such
as Viewpoint a 3D modeling company involved in
film and television and Caldera, a Linux
operating system development company. He
graduated from Brigham Young University with a
bachelors degree in Psychology.
Lee Houghton, VP Manufacturing/Quality
Assurance Mr. Houghton serves as VP
Manufacturing/Quality Assurance. Mr. Houghton has
worked 16 years in the cabinet manufacturing
industry in manufacturing/assembly, sales,
estimator, and general manager. Mr. Houghton
holds a B.S. degree in Accounting.
8
Technology Timeline
1986
Dr. Vaughn R Cook begins work in Energy Medicine
and Bio-energetic Testing.
1988
Develops Omega AcuBase System, Registered with
FDA.
1997
Sells Omega AcuBase technology to BioMeridian
International.
2001
Begins development of LSA System.
2004
Incorporates ZYTO Corp, a Nevada corporation.
ZYTO purchases LSA technology from Dr. Cook.
2006
Reverse merger into what is now ZYTO Corp, a
Delaware corporation (holding company).
9
TECHNOLOGY
ZYTO technology links computers to humans (and
pets) and collects information through a process
called a bio-survey. Health professionals use
LSA Pro and Balance bio-surveys to give them more
information about their patients. You can think
of it as an extension of the health
history. When a person puts her hand on the hand
cradle, ZYTO software begins an automatic
stimulus-response sequence. Essentially the
computer asks questions and the persons body
answers.
The Compass is a consumer application being
marketed through direct marketing companies who
sell nutritional products.
EVOX is an add-on of the LSA Pro. This package
opens new opportunities for stress assessment and
management. and enhances the health
professionals ability to individualize patient
care.
In 2008 ZYTO will launch more consumer
applications that will be available for download
direct to cell phones and through the internet.
These applications will expand the bio-survey
process to applications not related to health.
Future applications of ZYTO technology include
performance (productivity) enhancement and
accelerated learning.
10
Product Mix/ Distribution Channels
Health Professionals Direct Marketing
Pet Consumer
Direct
Scheduled for release in 2008 is Pet Messenger.
This is targeted to the Veterinary and Pet
Consumer Markets.
ZYTOs initial products are designed for and
sold only to healthcare professionals. These
include
A recent release for Direct Marketing companies
selling nutritional supplements is the Compass.
This is considered a consumer product.
Under development and scheduled for 2008 release
are ZYTO applications for the Consumer Market
that will be delivered through cell phones and
other devices via the internet.
11
Market Size
Health Professionals Direct Marketing
Pet Consumer
Direct
Pet Messenger is targeted primarily for the U.S.
and European Markets. Projected Sales Worldwide
10,000 Estimated worth
U.S.A. 3,000,000 Worldwide 30,000,000 CAM
(Complementary and Alternative) use by patients
in U.S.A. 70 1 market penetration is worth
approximately
U.S.A. 10,000,000 Worldwide 30,000,000 1
market penetration is worth approximately
Even though there are an estimated 4B cell phones
in the world, for projection purposes ZYTO counts
on 1B being in the hands of potential
customers. 1 market penetration is worth
approximately
49M one time 6M annually
319M one time 384M annually
1.6B one time 198M annually
1.2B annually
12
5-year projections
13
CUSTOMER EXPERIENCE
These are typical of reviews ZYTO regularly
receives from healthcare professionals who are
customers.
"I work at an Integrative Medical department in
one of the top ten heart/stroke hospitals in the
country. I've been doing EAV point testing since
1991 but I didn't want to be touching hands and
feet for the rest of my life. The LSA is much
quicker and gives me more information. - Jane
Oelke Ph.D., N.D. Michigan
"I really like the LSA system because it takes
the operator out of the sequence, the effect of
the operator is minimized, you want to have the
ability to know where to go next but you don't
want to effect the testing. - Bill Wolfe D.D.S.
New Mexico
14
Health Professional Market Strategy
In the health professional market ZYTO teams up
with companies whose interests are complementary.
SAM Strategic Alliance Member Co.
These are nutraceutical companies who sell
products to healthcare professionals. SAMs
benefit by selling more product when their
customers incorporate the ZYTO Balance and LSA
Pro into their practices. SAM companies
facilitate the introduction of ZYTO technology to
their customers.
Clinic Staff Customer
When ZYTO technology is sold to SAM customers,
ZYTO and the SAM company cooperate in the
training and implementation process. The goal is
quick, profitable implementation.
ZYTO Sales Team
ZYTO sales personnel are assigned to specific SAM
companies. This allows for maximum continuity
and coordination and well as a point person for
SAM customers.
15
Health Professional Market Strategy
SAM Strategic Alliance Member Co.
Because clinicians have ready access to reliable
prescriptive data they are able to dispense more
products to more patients. This has significant
bottom-line benefits to the SAM.
Coordination of marketing efforts to keep SAM
companies in the loop allows ZYTO to offer
further buying incentives.
Clinic Staff Customer
The Clinic Staff is the focus of attention. All
ZYTO efforts are designed to make the clinic
money by succeeding more rapidly as the result of
selecting the most appropriate products for each
individual patient.
ZYTO Team
The ZYTO team remains in contact with the Clinic
Staff to insure they are trained on all aspects
of the ZYTO technology and comfortable using it.
Patient/Client
Patients benefit because their nutriceutical
combination is specific for them. They are more
compliant because the LSA System demonstrates to
them the benefit they will receive from following
the practitioners orders.
16
GROWTH STRATEGY
ZYTOs growth strategy is a cash flow strategy.
The first objective is to close a sufficient
number of sales to allow the company to operate
from monthly subscription payments. This will
happen at approximately 4,000 sales. Beyond that
point cash flow can be available for expansion
applications.
In addition to this current focus, ZYTO is
developing consumer applications for its
technology cross-pollinating consumers with
health professionals and partnering with other
technology companies to deploy consumer
applications in various market segments.
17
PROFITABILITY

• ZYTOs product lineup consists primarily of
  software.
• Product development costs are absorbed on the
  front and cost of product thereafter is very low.
  
• This makes incremental sales very profitable, and
  gives ZYTO the luxury of flexibility
• flexibility to implement subscription based
  revenue model
• flexibility to explore bolder marketing
  alternatives
• flexibility to partner in more creative ways
• flexibility to make market share its initial
  primary objective